Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Plettenberg

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
AIDS Care|February 29, 2020
Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapyMichael Sabranski, Gesa Erdbeer, Ina Sonntag, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study)Anthony Lamarca, Nathan Clumeck, Andreas Plettenberg, et al.
AIDS (London, England)|June 26, 2003
Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphomaChristian Hoffmann, Eva Wolf, Gerd Fätkenheuer, et al.
Journal of the International AIDS Society|November 15, 2014
Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapyGesa Erdbeer, Michael Sabranski, Ina Sonntag, et al.
Journal of the International AIDS Society|November 15, 2014
Intermittent viraemia and immune reconstitution in patients with more than 10-15 years of antiretroviral therapy: baseline values still matterGesa Erdbeer, Michael Sabranski, Ina Sonntag, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 27, 2011
Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranesHelmut Schöfer, Roswitha Bruns, Isaak Effendy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Blood|May 21, 2005
AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotypingChristian Hoffmann, Markus Tiemann, Carsten Schrader, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 29, 2005
[Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology]Helmut Schöfer, Norbert Brockmeyer, Joachim Dissemond, et al.
Vaccine|October 23, 2013
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled studyThomas Harrer, Andreas Plettenberg, Keikawus Arastéh, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
AIDS Care|February 29, 2020
Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapyMichael Sabranski, Gesa Erdbeer, Ina Sonntag, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study)Anthony Lamarca, Nathan Clumeck, Andreas Plettenberg, et al.
AIDS (London, England)|June 26, 2003
Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphomaChristian Hoffmann, Eva Wolf, Gerd Fätkenheuer, et al.
Journal of the International AIDS Society|November 15, 2014
Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapyGesa Erdbeer, Michael Sabranski, Ina Sonntag, et al.
Journal of the International AIDS Society|November 15, 2014
Intermittent viraemia and immune reconstitution in patients with more than 10-15 years of antiretroviral therapy: baseline values still matterGesa Erdbeer, Michael Sabranski, Ina Sonntag, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 27, 2011
Diagnosis and treatment of Staphylococcus aureus infections of the skin and mucous membranesHelmut Schöfer, Roswitha Bruns, Isaak Effendy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Blood|May 21, 2005
AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotypingChristian Hoffmann, Markus Tiemann, Carsten Schrader, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 29, 2005
[Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology]Helmut Schöfer, Norbert Brockmeyer, Joachim Dissemond, et al.
Vaccine|October 23, 2013
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled studyThomas Harrer, Andreas Plettenberg, Keikawus Arastéh, et al.
Pageof 4